It isn’t that Wall Street doubts the massive opportunity to treat hundreds of millions of people with obesity worldwide; ...

Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most of those gains flowing to Eli Lilly and Novo Nordisk, the dominant ...

Cheesecake Factory gains nearly 5% premarket as JCP Investment Management pushes for a spinoff of three smaller brands into a separate company. Eli Lilly sues three companies for selling ...

Over the last month, Dell and Super Micro have been sparring in the headlines with new product releases. Just two weeks ago, ...

It will build a new factory to ramp up production of unapproved ... at the top of the heap in pharmaceuticals. The article "Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top ...

VK2735 is a dual GLP-1/GIP receptor agonist similar to Eli Lilly's (LLY) blockbuster weight loss drug Zepbound ... On the ...

An Eli Lilly official said decades of insulin research and manufacturing ... What's more, the company announced plans to ...

An Eli Lilly official said decades of insulin research ... plans to spend more than $1 billion on a state-of-the-art insulin factory in Germany by 2029. Weight loss drugs are among the most ...

UK chancellor Rachel Reeves has announced a £40bn tax increase, the biggest in a generation, with business bearing the brunt ...

Pharmaceutical company Eli Lilly and Company lost $28 billion in valuation ... Related: Company building major Colorado factory avoids NYSE delisting Mayor declares win for $500M downtown funding vote ...

The US bond market, already stung by the worst selloff in six months, now heads into a crucial two-week stretch that will ...